Related references
Note: Only part of the references are listed.Population pharmacokinetics of anidulafungin in ICU patients assessing inter- and intrasubject variability
Iasonas Kapralos et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program
Michael A. Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum
Renato Kovacs et al.
MICROORGANISMS (2021)
In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris
Unai Caballero et al.
ANTIBIOTICS-BASEL (2021)
In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms
Fruzsina Nagy et al.
MEDICAL MYCOLOGY (2021)
Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades
Zoltan Papp et al.
PATHOGENS (2021)
Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients
Xuemei Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak
Brittany O'Brien et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Colistin interacts synergistically with echinocandins against Candida auris
A. L. Bidaud et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
Amir Nutman et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae : interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data
Chenyan Zhao et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)
M. C. Arendrup et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
In vitro synergy of isavuconazole in combination with colistin against Candida auris
Patrick Schwarz et al.
SCIENTIFIC REPORTS (2020)
Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data
Alba Cecilia Ruiz-Gaitan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Tissue Distribution and Penetration of Isavuconazole at the Site of Infection in Experimental Invasive Aspergillosis in Mice with Underlying Chronic Granulomatous Disease
Annie Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy
E. Furfaro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria
Mark J. Biagi et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism
A. L. Bidaud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting
Nikki Kenters et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults
Roeland E. Wasmann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinations
M. J. E. Brill et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris
Guillermo Quindos et al.
INTERNATIONAL MICROBIOLOGY (2018)
We can do better: a fresh look at echinocandin dosing
Justin C. Bader et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris
Hassan E. Eldesouky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
Romuald Bellmann et al.
INFECTION (2017)
Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats
Anne-Hortense Schmitt-Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris
Hamed Fakhim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
Lisa C. Martial et al.
CLINICAL PHARMACOKINETICS (2017)
Translational Pharmacometric Evaluation of Typical Antibiotic Broad-Spectrum Combination Therapies Against Staphylococcus Aureus Exploiting In Vitro Information
S. G. Wicha et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values
M. C. Arendrup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Prediction of in vivo and in vitro infection model results using a semimechanistic model of avibactam and aztreonam combination against multidrug resistant organisms
S. K. B. Sy et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure
Lisa C. Martial et al.
CLINICAL PHARMACOKINETICS (2016)
In vitro pharmacodynamic modelling of anidulafungin against Candida spp.
Sandra Gil-Alonso et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model
Ami F. Mohamed et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Inhibitory and Fungicidal Effects of Antifungal Drugs against Aspergillus Species in the Presence of Serum
Antigoni Elefanti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Elisabet I. Nielsen et al.
PHARMACOLOGICAL REVIEWS (2013)
Antifungal Activity of Micafungin in Serum
Jun Ishikawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacokinetics and tissue distribution of anidulafungin in rats
Bharat Damle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Effects of serum on in vitro susceptibility testing of echinocandins
Zekaver Odabasi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents - minimum inhibitory concentration versus time-kill curves
Stephan Schmidt et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia
Tawanda Gumbo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis
Tawanda Gumbo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: Importance of persistence of caspofungin in tissues to understanding drug activity
A Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Combination treatment of invasive fungal infections
PK Mukherjee et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Share Paper
